breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Predicted mutations | |||||||
---|---|---|---|---|---|---|---|
evidence | seq id | position | mutation | freq | annotation | gene | description |
RA | NZ_CP022686 | 119,184 | T→G | 14.2% | F47V (TTT→GTT) | marB → | multiple antibiotic resistance protein MarB |
RA | NZ_CP022686 | 126,825 | G→T | 8.3% | G64C (GGT→TGT) | ydeE → | efflux MFS transporter YdeE |
RA | NZ_CP022686 | 298,027 | A→C | 13.3% | F60C (TTT→TGT) | chbC ← | PTS N,N'‑diacetylchitobiose transporter subunit IIC |
RA | NZ_CP022686 | 340,516 | A→C | 11.2% | F31V (TTT→GTT) | ydjK ← | MFS transporter |
RA | NZ_CP022686 | 360,227 | T→G | 21.9% | T35P (ACG→CCG) | yeaR ← | DUF1971 domain‑containing protein YeaR |
RA | NZ_CP022686 | 457,894 | Δ1 bp | 100% | pseudogene (288/997 nt) | CIW80_RS02445 ← | DUF968 domain‑containing protein |
RA | NZ_CP022686 | 560,880 | C→T | 100% | intergenic (+62/+53) | CIW80_RS03085 → / ← pilV | hypothetical protein/shufflon system plasmid conjugative transfer pilus tip adhesin PilV |
RA | NZ_CP022686 | 601,295 | T→G | 26.6% | V1607G (GTC→GGC) | irp1 → | yersiniabactin polyketide synthase HMWP1 |
RA | NZ_CP022686 | 601,302 | T→G | 27.5% | R1609R (CGT→CGG) | irp1 → | yersiniabactin polyketide synthase HMWP1 |
MC JC | NZ_CP022686 | 628,478 | Δ1,286 bp | 100% | [clbP] | [clbP] | |
RA | NZ_CP022686 | 651,848 | A→C | 14.0% | R238R (CGT→CGG) | clbJ ← | colibactin non‑ribosomal peptide synthetase ClbJ |
RA | NZ_CP022686 | 693,021 | A→C | 7.5% | T121P (ACG→CCG) | CIW80_RS03550 → | YaiO family outer membrane beta‑barrel protein |
RA | NZ_CP022686 | 756,115 | A→G | 100% | G181G (GGT→GGC) | galE ← | UDP‑glucose 4‑epimerase GalE |
RA | NZ_CP022686 | 765,001 | A→T | 13.2% | Y40N (TAC→AAC) | wcaM ← | colanic acid biosynthesis protein WcaM |
RA | NZ_CP022686 | 794,460 | C→T | 100% | A568V (GCG→GTG) | dgcE → | diguanylate cyclase |
RA | NZ_CP022686 | 829,435 | C→A | 14.4% | intergenic (‑24/+203) | gatY ← / ← fbaB | tagatose‑bisphosphate aldolase subunit GatY/class I fructose‑bisphosphate aldolase |
RA | NZ_CP022686 | 829,452 | G→T | 16.8% | intergenic (‑41/+186) | gatY ← / ← fbaB | tagatose‑bisphosphate aldolase subunit GatY/class I fructose‑bisphosphate aldolase |
RA | NZ_CP022686 | 829,467 | C→A | 23.2% | intergenic (‑56/+171) | gatY ← / ← fbaB | tagatose‑bisphosphate aldolase subunit GatY/class I fructose‑bisphosphate aldolase |
RA | NZ_CP022686 | 881,742 | A→C | 20.9% | intergenic (+257/+130) | yohP → / ← dusC | protein YohP/tRNA dihydrouridine(16) synthase DusC |
RA | NZ_CP022686 | 896,395 | T→G | 14.6% | W17G (TGG→GGG) | yeiG → | S‑formylglutathione hydrolase |
RA | NZ_CP022686 | 917,427:1 | +TT | 100% | intergenic (+130/‑91) | yeiP → / → yeiQ | elongation factor P‑like protein YeiP/mannitol dehydrogenase family protein |
RA | NZ_CP022686 | 957,112 | T→G | 7.6% | T89P (ACC→CCC) | ccmA ← | cytochrome c biogenesis heme‑transporting ATPase CcmA |
RA | NZ_CP022686 | 1,011,397 | T→A | 9.4% | intergenic (‑246/‑27) | glpT ← / → glpA | glycerol‑3‑phosphate transporter/anaerobic glycerol‑3‑phosphate dehydrogenase subunit A |
RA | NZ_CP022686 | 1,065,997 | A→C | 11.9% | A30A (GCT→GCG) | yfbS ← | SLC13 family permease |
RA | NZ_CP022686 | 1,100,906 | C→G | 12.6% | G200R (GGC→CGC) | aroC ← | chorismate synthase |
RA | NZ_CP022686 | 1,137,229 | A→C | 7.7% | R243R (CGT→CGG) | emrK ← | multidrug efflux MFS transporter periplasmic adaptor subunit EmrK |
RA | NZ_CP022686 | 1,197,147 | T→G | 15.3% | L76R (CTG→CGG) | murQ → | N‑acetylmuramic acid 6‑phosphate etherase |
RA | NZ_CP022686 | 1,209,908 | T→G | 19.6% | D396A (GAC→GCC) | eutH ← | ethanolamine utilization protein EutH |
RA | NZ_CP022686 | 1,278,783 | T→G | 7.4% | D242A (GAC→GCC) | bamB ← | outer membrane protein assembly factor BamB |
RA | NZ_CP022686 | 1,360,724 | G→T | 8.3% | intergenic (‑59/+265) | kgtP ← / ← rrf | alpha‑ketoglutarate permease/5S ribosomal RNA |
RA | NZ_CP022686 | 1,371,081 | C→A | 19.1% | P32Q (CCA→CAA) | bamD → | outer membrane protein assembly factor BamD |
RA | NZ_CP022686 | 1,464,955 | G→T | 6.7% | E158* (GAA→TAA) | pphB → | protein‑serine/threonine phosphatase |
RA | NZ_CP022686 | 1,479,607 | A→C | 14.3% | intergenic (‑16/+177) | ftsB ← / ← ygbE | cell division protein FtsB/DUF3561 family protein |
RA | NZ_CP022686 | 1,504,289 | T→G | 16.9% | R242R (CGT→CGG) | CIW80_RS07520 → | YgcG family protein |
RA | NZ_CP022686 | 1,504,361 | G→T | 22.4% | V266V (GTG→GTT) | CIW80_RS07520 → | YgcG family protein |
RA | NZ_CP022686 | 1,546,985 | A→T | 11.3% | intergenic (+7/‑27) | CIW80_RS07705 → / → CIW80_RS07710 | tRNA‑Met/tRNA‑Met |
RA | NZ_CP022686 | 1,546,995 | G→T | 11.3% | intergenic (+17/‑17) | CIW80_RS07705 → / → CIW80_RS07710 | tRNA‑Met/tRNA‑Met |
RA | NZ_CP022686 | 1,632,501 | T→G | 9.5% | V166G (GTT→GGT) | arcC → | carbamate kinase |
RA | NZ_CP022686 | 1,633,901 | T→G | 9.9% | T235P (ACG→CCG) | yqeB ← | selenium‑dependent molybdenum cofactor biosynthesis protein YqeB |
RA | NZ_CP022686 | 1,674,231 | A→T | 14.8% | V186E (GTA→GAA) | ygfB ← | UPF0149 family protein YgfB |
RA | NZ_CP022686 | 1,674,244 | T→G | 14.0% | T182P (ACC→CCC) | ygfB ← | UPF0149 family protein YgfB |
RA | NZ_CP022686 | 1,674,248 | T→G | 14.9% | Q180H (CAA→CAC) | ygfB ← | UPF0149 family protein YgfB |
RA | NZ_CP022686 | 1,833,745 | T→G | 23.2% | N468H (AAC→CAC) | gspD ← | type II secretion system secretin GspD |
RA | NZ_CP022686 | 1,954,923 | T→G | 18.4% | T92P (ACG→CCG) | ttdR ← | DNA‑binding transcriptional activator TtdR |
RA | NZ_CP022686 | 2,016,175 | T→G | 8.3% | noncoding (99/377 nt) | rnpB ← | RNase P RNA component class A |
RA | NZ_CP022686 | 2,016,225 | T→G | 9.0% | noncoding (49/377 nt) | rnpB ← | RNase P RNA component class A |
RA | NZ_CP022686 | 2,027,390 | A→C | 9.1% | K80N (AAA→AAC) | agaE → | PTS N‑acetylgalactosamine transporter subunit IID |
RA | NZ_CP022686 | 2,049,089 | T→G | 17.6% | N256T (AAC→ACC) | deaD ← | ATP‑dependent RNA helicase DeaD |
RA | NZ_CP022686 | 2,049,094 | G→T | 13.6% | T254T (ACC→ACA) | deaD ← | ATP‑dependent RNA helicase DeaD |
RA | NZ_CP022686 | 2,049,097 | A→T | 13.7% | R253R (CGT→CGA) | deaD ← | ATP‑dependent RNA helicase DeaD |
RA | NZ_CP022686 | 2,076,556 | C→G | 7.7% | intergenic (+26/‑207) | ispB → / → sfsB | octaprenyl diphosphate synthase/DNA‑binding transcriptional regulator SfsB |
RA | NZ_CP022686 | 2,110,457 | T→G | 13.6% | K12N (AAA→AAC) | rplM ← | 50S ribosomal protein L13 |
RA | NZ_CP022686 | 2,110,465 | T→G | 15.2% | T10P (ACC→CCC) | rplM ← | 50S ribosomal protein L13 |
RA | NZ_CP022686 | 2,148,115 | T→G | 13.8% | L126R (CTG→CGG) | panF → | sodium/pantothenate symporter |
RA | NZ_CP022686 | 2,148,160 | T→G | 10.3% | V141G (GTG→GGG) | panF → | sodium/pantothenate symporter |
RA | NZ_CP022686 | 2,172,177 | A→C | 5.4% | G87G (GGT→GGG) | smg ← | DUF494 family protein Smg |
RA | NZ_CP022686 | 2,179,916 | G→T | 9.1% | R22R (CGC→CGA) | rplQ ← | 50S ribosomal protein L17 |
RA | NZ_CP022686 | 2,188,239 | G→T | 10.1% | intergenic (‑108/+57) | rplN ← / ← rpsQ | 50S ribosomal protein L14/30S ribosomal protein S17 |
RA | NZ_CP022686 | 2,214,419 | T→C | 100% | K43R (AAA→AGA) | rpsL ← | 30S ribosomal protein S12 |
RA | NZ_CP022686 | 2,215,206 | C→A | 6.0% | A41S (GCT→TCT) | tusC ← | sulfurtransferase complex subunit TusC |
RA | NZ_CP022686 | 2,215,213 | G→C | 6.2% | F38L (TTC→TTG) | tusC ← | sulfurtransferase complex subunit TusC |
RA | NZ_CP022686 | 2,226,139 | A→C | 5.8% | D9A (GAC→GCC) | crp → | cAMP‑activated global transcriptional regulator CRP |
RA | NZ_CP022686 | 2,239,252 | C→A | 7.3% | intergenic (+57/‑195) | cysG → / → yhfL | siroheme synthase CysG/YhfL family protein |
RA | NZ_CP022686 | 2,320,775 | C→T | 100% | G274S (GGC→AGC) | CIW80_RS11675 ← | DNA‑processing protein DprA |
JC | NZ_CP022686 | 2,342,044 | Δ3 bp | 5.2% | coding (533‑535/1278 nt) | livM ← | branched chain amino acid ABC transporter permease LivM |
RA | NZ_CP022686 | 2,357,322 | T→A | 15.9% | S36R (AGT→AGA) | dcrB → | phage sensitivity protein DcrB |
RA | NZ_CP022686 | 2,386,496 | T→G | 9.5% | K417N (AAA→AAC) | prlC ← | oligopeptidase A |
RA | NZ_CP022686 | 2,394,287 | T→G | 17.0% | N115T (AAC→ACC) | chuS ← | hematinate‑forming heme oxygenase ChuS |
RA | NZ_CP022686 | 2,394,291 | C→G | 17.6% | E114Q (GAA→CAA) | chuS ← | hematinate‑forming heme oxygenase ChuS |
RA | NZ_CP022686 | 2,408,861 | Δ1 bp | 100% | pseudogene (1097/3115 nt) | mdtF → | multidrug efflux pump RND permease MdtF |
RA | NZ_CP022686 | 2,470,422 | T→G | 14.2% | K72N (AAA→AAC) | glyS ← | glycine‑‑tRNA ligase subunit beta |
RA | NZ_CP022686 | 2,478,444 | C→G | 6.8% | P2A (CCT→GCT) | xylG → | D‑xylose ABC transporter ATP‑binding protein |
RA | NZ_CP022686 | 2,574,429 | T→G | 13.7% | N230T (AAC→ACC) | CIW80_RS12895 ← | class II fructose‑bisphosphate aldolase family protein |
JC | NZ_CP022686 | 2,590,563 | +TTGG | 100% | coding (109/153 nt) | CIW80_RS26455 → | hypothetical protein |
RA | NZ_CP022686 | 2,703,299 | A→C | 7.8% | intergenic (‑203/‑277) | yieP ← / → CIW80_RS13540 | FadR/GntR family transcriptional regulator/16S ribosomal RNA |
RA | NZ_CP022686 | 2,717,385 | T→G | 8.2% | F96V (TTT→GTT) | ilvA → | threonine ammonia‑lyase, biosynthetic |
RA | NZ_CP022686 | 2,736,585 | T→A | 8.9% | Y183N (TAC→AAC) | rffA → | dTDP‑4‑amino‑4,6‑dideoxygalactose transaminase |
RA | NZ_CP022686 | 2,743,563 | T→G | 9.0% | noncoding (65/87 nt) | CIW80_RS13750 → | tRNA‑Leu |
RA | NZ_CP022686 | 2,758,128 | A→C | 7.2% | K40N (AAA→AAC) | yifL → | lipoprotein |
RA | NZ_CP022686 | 2,758,144 | A→C | 10.5% | T46P (ACG→CCG) | yifL → | lipoprotein |
RA | NZ_CP022686 | 2,758,153 | A→C | 9.6% | T49P (ACG→CCG) | yifL → | lipoprotein |
RA | NZ_CP022686 | 2,758,168 | A→C | 5.9% | N54H (AAC→CAC) | yifL → | lipoprotein |
RA | NZ_CP022686 | 2,769,196 | A→C | 18.6% | F47C (TTT→TGT) | rarD ← | EamA family transporter RarD |
RA | NZ_CP022686 | 2,834,886 | A→C | 13.1% | K597N (AAA→AAC) | polA → | DNA polymerase I |
RA | NZ_CP022686 | 2,834,898 | A→C | 10.1% | K601N (AAA→AAC) | polA → | DNA polymerase I |
RA | NZ_CP022686 | 2,868,753 | T→G | 10.6% | T18P (ACC→CCC) | fdoH ← | formate dehydrogenase O subunit beta |
RA | NZ_CP022686 | 2,871,449 | T→G | 13.3% | D140A (GAC→GCC) | fdnG ← | formate dehydrogenase‑N subunit alpha |
RA | NZ_CP022686 | 2,920,428 | A→C | 12.8% | K68N (AAA→AAC) | CIW80_RS14610 → | bifunctional UDP‑sugar hydrolase/5'‑nucleotidase |
RA | NZ_CP022686 | 2,994,693 | T→G | 10.2% | W162G (TGG→GGG) | yjaH → | DUF1481 domain‑containing protein |
RA | NZ_CP022686 | 3,114,640 | A→C | 5.3% | G40G (GGT→GGG) | CIW80_RS15500 ← | ABC transporter ATP‑binding protein |
RA | NZ_CP022686 | 3,163,945 | A→C | 6.9% | T397P (ACG→CCG) | melA → | alpha‑galactosidase |
JC | NZ_CP022686 | 3,196,873 | +GCGTAATCGGTT | 100% | coding (944/1122 nt) | ampC ← | BlaEC family class C beta‑lactamase |
RA | NZ_CP022686 | 3,265,084 | T→G | 17.8% | N77T (AAC→ACC) | ytfJ ← | YtfJ family protein |
RA | NZ_CP022686 | 3,310,876 | A→C | 5.5% | R650R (CGT→CGG) | valS ← | valine‑‑tRNA ligase |
RA | NZ_CP022686 | 3,348,345 | G→T | 8.4% | intergenic (‑161/‑39) | CIW80_RS16685 ← / → CIW80_RS26495 | inovirus Gp2 family protein/hypothetical protein |
RA | NZ_CP022686 | 3,390,629 | C→A | 12.4% | W138C (TGG→TGT) | sgcX ← | M42 family metallopeptidase |
RA | NZ_CP022686 | 3,424,795 | A→C | 100% | intergenic (‑41/+27) | yjiJ ← / ← yjiK | MFS transporter/YjiK family protein |
RA | NZ_CP022686 | 3,461,215 | A→T | 15.2% | intergenic (‑24/+11) | CIW80_RS17335 ← / ← CIW80_RS17340 | tRNA‑Leu/tRNA‑Leu |
RA | NZ_CP022686 | 3,461,225 | T→G | 13.9% | intergenic (‑34/+1) | CIW80_RS17335 ← / ← CIW80_RS17340 | tRNA‑Leu/tRNA‑Leu |
RA | NZ_CP022686 | 3,461,229 | T→G | 17.9% | noncoding (84/87 nt) | CIW80_RS17340 ← | tRNA‑Leu |
RA | NZ_CP022686 | 3,461,231 | C→G | 14.9% | noncoding (82/87 nt) | CIW80_RS17340 ← | tRNA‑Leu |
RA | NZ_CP022686 | 3,461,247 | A→C | 13.6% | noncoding (66/87 nt) | CIW80_RS17340 ← | tRNA‑Leu |
RA | NZ_CP022686 | 3,516,069 | T→G | 6.3% | V211G (GTT→GGT) | nhaA → | Na+/H+ antiporter NhaA |
RA | NZ_CP022686 | 3,516,093 | T→G | 6.1% | V219G (GTG→GGG) | nhaA → | Na+/H+ antiporter NhaA |
RA | NZ_CP022686 | 3,526,230 | G→T | 9.0% | A209S (GCC→TCC) | dapB → | 4‑hydroxy‑tetrahydrodipicolinate reductase |
RA | NZ_CP022686 | 3,604,564 | G→T | 14.2% | intergenic (+80/‑151) | lpxC → / → secM | UDP‑3‑O‑acyl‑N‑acetylglucosamine deacetylase/secA translation cis‑regulator SecM |
RA | NZ_CP022686 | 3,656,188 | A→G | 100% | S549P (TCC→CCC) | htrE ← | outer membrane usher protein |
RA | NZ_CP022686 | 3,680,536 | A→C | 6.4% | V45G (GTT→GGT) | btuF ← | vitamin B12 ABC transporter substrate‑binding protein BtuF |
RA | NZ_CP022686 | 3,734,367 | T→G | 23.6% | F225V (TTT→GTT) | yafD → | endonuclease/exonuclease/phosphatase family protein |
RA | NZ_CP022686 | 3,734,380 | T→G | 13.2% | L229R (CTC→CGC) | yafD → | endonuclease/exonuclease/phosphatase family protein |
RA | NZ_CP022686 | 3,736,531 | T→G | 7.8% | N74H (AAC→CAC) | mltD ← | murein transglycosylase D |
RA | NZ_CP022686 | 3,770,524 | T→G | 9.0% | intergenic (‑260/+203) | CIW80_RS26265 ← / ← CIW80_RS18890 | ATP‑binding protein/hypothetical protein |
RA | NZ_CP022686 | 3,792,805 | A→G | 100% | Y421C (TAC→TGC) | fucP → | L‑fucose:H+ symporter permease |
RA | NZ_CP022686 | 3,797,481 | T→G | 14.4% | L130V (TTA→GTA) ‡ | CIW80_RS19065 → | LacI family DNA‑binding transcriptional regulator |
RA | NZ_CP022686 | 3,797,483 | A→T | 16.7% | L130F (TTA→TTT) ‡ | CIW80_RS19065 → | LacI family DNA‑binding transcriptional regulator |
RA | NZ_CP022686 | 3,798,080 | T→G | 7.8% | R329R (CGT→CGG) | CIW80_RS19065 → | LacI family DNA‑binding transcriptional regulator |
RA | NZ_CP022686 | 3,798,092 | C→A | 9.3% | F333L (TTC→TTA) | CIW80_RS19065 → | LacI family DNA‑binding transcriptional regulator |
RA | NZ_CP022686 | 3,806,262 | G→T | 8.9% | D1585Y (GAT→TAT) | cdiA → | contact‑dependent inhibition effector tRNA nuclease |
RA | NZ_CP022686 | 3,828,913 | T→G | 6.6% | G131G (GGT→GGG) | CIW80_RS19170 → | hypothetical protein |
RA | NZ_CP022686 | 3,868,846 | T→G | 10.8% | T383P (ACG→CCG) | ecpC ← | fimbrial usher EcpC |
RA | NZ_CP022686 | 3,935,324 | T→G | 14.3% | N705T (AAC→ACC) | lacZ ← | beta‑galactosidase |
RA | NZ_CP022686 | 3,942,556 | T→G | 5.6% | T121P (ACG→CCG) | yaiO ← | YaiO family outer membrane beta‑barrel protein |
RA | NZ_CP022686 | 3,981,933 | T→G | 12.2% | intergenic (+70/‑86) | proY → / → malZ | proline‑specific permease ProY/maltodextrin glucosidase |
RA | NZ_CP022686 | 4,014,256 | G→T | 11.0% | intergenic (+102/‑242) | bolA → / → tig | transcriptional regulator BolA/trigger factor |
RA | NZ_CP022686 | 4,056,951 | C→A | 16.5% | H134N (CAC→AAC) | adk → | adenylate kinase |
RA | NZ_CP022686 | 4,056,962 | C→A | 15.7% | F137L (TTC→TTA) | adk → | adenylate kinase |
RA | NZ_CP022686 | 4,079,363 | A→C | 15.2% | A158A (GCT→GCG) | ybbO ← | NADP(+)‑dependent aldehyde reductase |
RA | NZ_CP022686 | 4,368,341 | T→G | 12.7% | D47A (GAC→GCC) | ybiY ← | glycyl‑radical enzyme activating protein |
RA | NZ_CP022686 | 4,440,297 | T→A | 10.9% | V785D (GTT→GAT) | ftsK → | DNA translocase FtsK |
RA | NZ_CP022686 | 4,440,324 | C→A | 14.1% | P794Q (CCG→CAG) | ftsK → | DNA translocase FtsK |
RA | NZ_CP022686 | 4,587,120 | G→T | 12.5% | S599R (AGC→AGA) | CIW80_RS22915 ← | enterotoxin |
RA | NZ_CP022686 | 4,606,974 | A→T | 5.5% | L31H (CTT→CAT) | CIW80_RS23025 ← | lysophospholipid acyltransferase family protein |
RA | NZ_CP022686 | 4,632,182 | T→G | 11.9% | R276R (CGT→CGG) | mchF → | microcin export transporter peptidase/ATP‑binding subunit MchF |
RA | NZ_CP022686 | 4,678,041 | A→C | 20.7% | intergenic (+39/‑82) | agn43 → / → CIW80_RS23450 | autotransporter adhesin Ag43/hypothetical protein |
RA | NZ_CP022686 | 4,764,877 | T→G | 17.0% | intergenic (‑57/‑204) | ycfT ← / → lolC | acyltransferase family protein/lipoprotein‑releasing ABC transporter permease subunit LolC |
RA | NZ_CP022686 | 4,780,176 | A→C | 12.0% | intergenic (‑75/+95) | phoP ← / ← purB | two‑component system response regulator PhoP/adenylosuccinate lyase |
RA | NZ_CP022686 | 4,780,179 | A→C | 12.1% | intergenic (‑78/+92) | phoP ← / ← purB | two‑component system response regulator PhoP/adenylosuccinate lyase |
RA | NZ_CP022686 | 4,814,961 | T→G | 9.9% | F61C (TTT→TGT) | CIW80_RS24295 → | phage tail protein |
RA | NZ_CP022686 | 4,839,687 | T→G | 12.4% | N144T (AAC→ACC) | minD ← | septum site‑determining protein MinD |
RA | NZ_CP022686 | 4,839,695 | A→T | 13.5% | I141I (ATT→ATA) | minD ← | septum site‑determining protein MinD |
RA | NZ_CP022686 | 4,850,769 | A→T | 6.4% | L220Q (CTG→CAG) | ycgB ← | SpoVR family protein |
RA | NZ_CP022686 | 4,852,202 | A→C | 7.9% | N149T (AAC→ACC) | dadA → | D‑amino acid dehydrogenase |
RA | NZ_CP022686 | 4,870,912 | Δ1 bp | 100% | intergenic (‑108/‑120) | dhaK ← / → dhaR | dihydroxyacetone kinase subunit DhaK/dihydroxyacetone kinase operon transcriptional regulator DhaR |
RA | NZ_CP022686 | 4,905,170 | T→G | 11.5% | V99G (GTT→GGT) | CIW80_RS24815 → | coenzyme F390 synthetase |
RA | NZ_CP022686 | 4,919,022 | T→G | 11.2% | S329R (AGC→CGC) | adhE ← | bifunctional acetaldehyde‑CoA/alcohol dehydrogenase |
RA | NZ_CP022686 | 5,000,015 | T→G | 11.3% | F156V (TTT→GTT) | CIW80_RS25310 → | ABC transporter ATP‑binding protein |
RA | NZ_CP022686 | 5,001,157 | G→T | 16.7% | D161Y (GAT→TAT) | ompG → | monomeric porin OmpG |
RA | NZ_CP022686 | 5,043,648 | G→C | 5.2% | V1093V (GTG→GTC) | CIW80_RS25525 → | EntS/YbdA MFS transporter |
RA | NZ_CP022686 | 5,043,951 | T→C | 8.9% | G1194G (GGT→GGC) | CIW80_RS25525 → | EntS/YbdA MFS transporter |
JC | pHH‑29_RBS | 1,534 | Δ13 bp | 20.4% | coding (36‑48/570 nt) | Aldafermin (NGM282) → | |
RA | pHH‑29_RBS | 2,898 | Δ1 bp | 8.4% | intergenic (‑477/+231) | mok CDS ← / ← putative HTH domain protein (MarR‑like) | –/– |
RA | pHH‑29_RBS | 2,899 | Δ1 bp | 100% | intergenic (‑478/+230) | mok CDS ← / ← putative HTH domain protein (MarR‑like) | –/– |
RA | pHH‑29_RBS | 2,943 | A→T | 8.8% | intergenic (‑522/+186) | mok CDS ← / ← putative HTH domain protein (MarR‑like) | –/– |
RA | pHH‑29_RBS | 2,946 | G→T | 7.8% | intergenic (‑525/+183) | mok CDS ← / ← putative HTH domain protein (MarR‑like) | –/– |
RA | pHH‑29_RBS | 2,947 | G→T | 6.6% | intergenic (‑526/+182) | mok CDS ← / ← putative HTH domain protein (MarR‑like) | –/– |
RA | pHH‑29_RBS | 2,953 | G→T | 11.5% | intergenic (‑532/+176) | mok CDS ← / ← putative HTH domain protein (MarR‑like) | –/– |
RA | pHH‑29_RBS | 2,954 | G→T | 8.3% | intergenic (‑533/+175) | mok CDS ← / ← putative HTH domain protein (MarR‑like) | –/– |
RA | pHH‑29_RBS | 3,601:1 | +A | 37.0% | intergenic (‑44/‑113) | putative HTH domain protein (MarR‑like) ← / → uncharacterized protein | –/– |
RA | pHH‑29_RBS | 3,607 | C→A | 31.5% | intergenic (‑50/‑107) | putative HTH domain protein (MarR‑like) ← / → uncharacterized protein | –/– |
RA | pHH‑29_RBS | 3,646 | C→A | 22.0% | intergenic (‑89/‑68) | putative HTH domain protein (MarR‑like) ← / → uncharacterized protein | –/– |
Unassigned missing coverage evidence | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
seq id | start | end | size | ←reads | reads→ | gene | description | |||
* | * | ÷ | NZ_CP022686 | 3726124–3731465 | 3731541–3731480 | 16–5418 | 70 [69] | [69] 71 | CIW80_RS18595–[CIW80_RS18620] | CIW80_RS18595,CIW80_RS18600,CIW80_RS18605,CIW80_RS18610,rrf,[CIW80_RS18620] |
* | * | ÷ | NZ_MW240712 | 189–2618 | 3084–2957 | 340–2896 | 17145 [15924] | [16029] 17069 | JNG15_RS00005–mobA | JNG15_RS00005,JNG15_RS00010,JNG15_RS00015,mobA |
Unassigned new junction evidence | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
* | ? | NZ_CP022686 | = 1410712 | 145 (0.820) | 15 (0.090) | 14/228 | NT | 9.0% | coding (454/1065 nt) | proW | glycine betaine/L‑proline ABC transporter permease ProW |
? | NZ_CP022686 | 1416322 = | 171 (1.050) | coding (641/1173 nt) | emrA | multidrug efflux MFS transporter periplasmic adaptor subunit EmrA | |||||
* | ? | NZ_CP022686 | = 1821855 | 186 (1.050) | 11 (0.060) | 11/248 | NT | 5.6% | coding (330/717 nt) | CIW80_RS09080 | K5 polysaccharide biosynthesis alpha‑UDP‑GlcNAc glycosyltransferase KfiA |
? | NZ_CP022686 | 2862182 = | NA (NA) | intergenic (‑30/‑99) | CIW80_RS14315/CIW80_RS14320 | alpha/beta hydrolase/ClbS/DfsB family four‑helix bundle protein | |||||
* | ? | NZ_CP022686 | 3322412 = | 141 (0.790) | 19 (0.110) | 13/248 | NT | 11.9% | coding (1690/1911 nt) | CIW80_RS16525 | site‑specific integrase |
? | NZ_CP022686 | 3369610 = | NA (NA) | intergenic (‑3/+8) | CIW80_RS16840/CIW80_RS16845 | restriction endonuclease/IS3‑like element ISEc52 family transposase | |||||
* | ? | NZ_CP022686 | = 3322414 | 144 (0.810) | 9 (0.050) | 9/248 | NT | 5.9% | coding (1692/1911 nt) | CIW80_RS16525 | site‑specific integrase |
? | NZ_CP022686 | = 3395240 | NA (NA) | pseudogene (10/1107 nt) | yjhR | helicase YjhR | |||||
* | ? | NZ_CP022686 | 3369610 = | NA (NA) | 11 (0.060) | 10/248 | NT | 5.0% | intergenic (‑3/+8) | CIW80_RS16840/CIW80_RS16845 | restriction endonuclease/IS3‑like element ISEc52 family transposase |
? | NZ_CP022686 | = 3375481 | 208 (1.170) | coding (958/1260 nt) | mtnK | S‑methyl‑5‑thioribose kinase |